Peginterferon Alfa-2b Therapy in Acute Hepatitis C: Impact of Onset of Therapy on Sustained Virologic Response

Background & Aims: Pegylated interferon therapy has not been adequately evaluated in acute hepatitis C virus (HCV) infection. This randomized trial assessed the efficacy, safety, and timing of pegylated interferon alfa-2b for treatment of acute hepatitis C. Methods: One hundred seventy-five pati...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2006-03, Vol.130 (3), p.632-638
Hauptverfasser:	Kamal, Sanaa M., Fouly, Amr E., Kamel, Refaat R., Hockenjos, Bridgette, Al Tawil, Ahmed, Khalifa, Khalifa E., He, Qi, Koziel, Margaret J., El Naggar, Khairy M., Rasenack, Jens, Afdhal, Nezam H.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Adult Antiviral Agents - therapeutic use Female Hepatitis C - drug therapy Hepatitis C - virology Humans Interferon-alpha - adverse effects Interferon-alpha - therapeutic use Male Middle Aged Polyethylene Glycols Prospective Studies Recombinant Proteins RNA, Viral - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!